Characteristics of Potential Lymphoma-inducing Cells in Mice Sensitive or Resistant to Lymphomagenesis by Radiation Leukemia Virus Variants

Cancer Research

Volumn 50, Issue 9, 1990, Pages 2554-2561

  Gokhman, Irina ^a   Peled, Alpha ^a   Haran Ghera, Nechama ^a  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BONE MARROW CELL; CARCINOGENICITY; CYTOCHEMISTRY; INTRAPERITONEAL DRUG ADMINISTRATION; LYMPHOMAGENESIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; RADIATION LEUKEMIA VIRUS; THYMOCYTE;

ANIMAL; ANTIGENS, CD4; ANTIGENS, CD8; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; ANTIGENS, SURFACE; BONE MARROW; CELL FRACTIONATION; CORTISONE; LEUKEMIA VIRUS, MURINE; LYMPHOMA; MICE; PHENOTYPE; T-LYMPHOCYTES;

EID: 0025274814     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Lonai, P., and Haran-Ghera, N. Genetic resistance to murine leukemia induced by different radiation leukemia virus variants; a comparative study on the role of the H-2 complex. Immunogenetics, 11: 21–29, 1980.
2. Haran-Ghera, N. Spontaneous and induced preleukemia cells in CS7BL/6 mice: Brief Communication. J. Natl. Cancer Inst., 60:707–710, 1978.
3. Lonai, P., Katz, E., and Haran-Ghera, N. Ir gene regulation of sensitivity to leukemogenesis by RadLV variants and its relationship to preleukemic cells. In: E. Skamene, P. A. L. Kongshaun, and M. Landy (eds.), Genetic Control of Natural Resistance to Infection and Malignancy, pp 321–328. Academic Press, London: 1980.
4. Lonai, P., Katz, E., and Haran-Ghera, N. Role of the major histocompatibility complex in resistance to viral leukemia; its effect on the preleukemic stage of leukemogenesis. Springer Semin. Immunopathol., 4:373–396,1982.
5. Haran-Ghera, N. Prothymocytes as target cells of T cell leukemogenesis. Surv. Immunol. Res., 4:19–26, 1985.
6. Haran-Ghera, N. Influence of host factors on leukemogenesis by the radiation leukemia virus. Isr. J. Med. Sci., 7: 17–25, 1971.
7. Haran-Ghera, N., Ben-Yaakov, M., and Peled, A. Immunologic characteristics in relation to high and low leukemogenic activity of radiation leukemia virus variants. J. Immunol., 118:600–606, 1977.
8. Goff, S., Trakman, P., and Baltimore, D. Isolation and properties of Moloney murine leukemia virus mutants; use of a rapid assay for release of virion reverse transcriptase. J. Virol., 38: 239–248, 1981.
9. Meruelo, D., Paolino, A., Flieger, M., Dworkin, J., Offer, M., Hirayama, N., and Ovary, Z. Functional properties of Ly 11.2 lymphocytes: a role for these cells in leukemia? J. Immunol., 125:2719–2726, 1980.
10. Rothenberg, E. A specific biosynthetic marker for immature thymic lymphoblasts. J. Exp. Med., 755: 140–154, 1982.
11. Mage, M. G., McHugh, L. L., and Rothstein, T. L. Mouse lymphocytes with and without surface immunoglobulin: preparative scale separation in polystyrene tissue culture dishes coated with specifically purified antiimmunoglobulin. J. Immunol. Methods, 15:47–56, 1977.
12. Krishan, A. Rapid flow cytofluorometric analysis of mammalian cell cycle by propidium iodide staining. J. Cell Biol., 66:188–191, 1975.
13. Lesley, J., Hyman, R., and Schulte, R. Evidence that the pgP-1 glycoprotein is expressed on thymus-homing progenitor cells of the thymus. Cell. Immunol., 91: 397–403, 1985.
14. Sonoko, H., Masataka, K., Yoshitaka, N., Morikazy, T., Tomie, T., Herzenberg, L. A., and Okumura, K. The glycolipid asialo GM1 as a new differentiation antigen of fetal thymocytes. J. Immunol., 125: 2284–2288, 1980.
15. Kadish, J. L., and Basch, R. S. Hematopoietic thymocyte precursors. I. Assay and kinetics of the appearance of progeny. J. Exp. Med., 143: 1082–1089, 1976.
16. Till, T. E., and McCulloch, E. A. A direct measurement of the radiation sensitivity of normal mouse bone marrow cells. Radiat. Res., 14: 213–220, 1961.
17. Chazan, R., and Haran-Ghera, N. The role of thymus subpopulations in “T” leukemia development. Cell. Immunol., 23:356–375, 1976.
18. Katz, E., Peled, A., and Haran-Ghera, N. Changes of H-2 antigen expression on thymocytes during leukemia development by radiation leukemia virus. Leuk. Res., 9:1219–1225, 1985.
19. Fowlkes, B. J., Edison, L., Mathieson, B. J., and Chused, J. M. Early T lymphocytes differentiation in vivo of adult intrathymic precursor cells. J. Exp. Med., 162:802–811, 1985.
20. Scollay, R., and Shortman, K. Identification of early stages of T lymphocyte development in the thymic cortex and medulla. J. Immunol., 134: 3632– 3638, 1985.
21. Scollay, R., Wilson, A., D’Amico, A., Kelly, K., Egerton, M., Pearse, M., Wu, L., and Shortman, K. Developmental status and reconstitution potential of subpopulations of murine thymocytes. Immunol. Rev., 104:81–120,1988.
22. Boniver, J., Decleve, A., Honsik, G, Lieberman, M., and Kaplan, H. S. Phenotypic characterization in mice of thymus target cells susceptible to productive infection by the radiation leukemia virus. J. Natl. Cancer Inst., 67:1139–1151,1981.
23. Goffinet, G., Houben-Defresne, M. P., and Boniver, J. Correlation of alkaline phosphatase activity to normal T cell differentiation and to radiation leukemia virus-induced preleukemic cells in C57BL mouse thymus. Cancer Res., 43: 5416–5426, 1983.
24. Lieberman, M., Decleve, A., Ricciardi-Castagnoli, P., Boniver, J., Finn, O. J., and Kaplan, H. S. Establishment, characterization and virus expression of cell lines derived from radiation and virus-induced lymphomas of C57BL/ Ka mice. Int. J. Cancer, 24: 168–177, 1979.
25. Meruelo, D., Lieberman, M., Ginzton, M., Deak, B., and McDevitt, H. O. Genetic control of radiation leukemic virus induced tumorigenesis. I. Role of the major murine histocompatibility complex, H-2. J. Exp. Med., 146: 1079–1087, 1977.
26. Cloyd, M. Characterization of target cells for MCF viruses in AKR mice. Cell, 32:217–225,1983.
27. O’Donnell, P. V., Woller, R., and Chu, A. Stages in development of mink cell focus-inducing (MCF) virus-accelerated leukemia in AKR mice. J. Exp. Med., 160:914–934, 1984.
28. Goodenow, M. M., and Lilly, F. Expression of differentiation and murine leukemia virus antigens on cells of primary tumors and cell lines derived from chemically induced lymphomas of RF/J mice. Proc. Natl. Acad. Sci. USA, 81:7612–7616, 1984.
29. Boyer, B., Gisselbrecht, S., Debre, P., McKenzie, I., and Levy, J. P. Genetic control of sensitivity to Moloney leukemia virus in mice. IV. Phenotypic heterogeneity of the leukemic mice. J. Immunol., 125:1415–1420, 1980.
30. Haran-Ghera, N., Rubio, N., Leef, F., and Goldstein, G. Characteristics of preleukemic cells induced in mice. Cell Immunol., 37: 308–314, 1978.
31. Lonai, P., Katz, E., Peled, H., and Haran-Ghera, N. H-2I-linked control of immunological resistance to viral leukemogenesis as a response to preleukemic cells. Immunogenetics, 12:423–427, 1981.
32. Peled, A. Cellular immune response induced by the radiation leukemia virus (RadLV). Leuk. Res., 1: 333–343, 1977.
33. Haran-Ghera, N., and Rubio, N. Immunologic characteristics in relation to high and low leukemogenic activity of radiation leukemia virus variants. II. Analysis of the immune response. J. Immunol., 118:607–611, 1977.